Effectiveness of Different Types of Silica Nanoparticles as Drug Carriers for Topical Delivery of GMDP into Peritoneal Macrophages of Women with Endometriosis

In: Silica Nanoparticles as Drug Delivery System for Immunomodulator GMDP (Biomedical & Nanomedical Technologies - Concise Monograph Series) · 2012 · pp. 51–58 · doi:10.1115/1.860021.ch6 · W2311826066
book-chapter OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-08-06

This study investigated silica nanoparticles as drug carriers for topical delivery of GMDP into peritoneal macrophages of women with endometriosis, finding potential for increased GMDP influence without significant negative effects on macrophage receptors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Taking into account all evidential results relating to low toxicity of APTES-modified and unmodified silica nanoparticles with a radius of 50 nm, its intensive interaction with the peritoneal macrophages, as well as the absence of the pronounced effect of the silica nanoparticles on the expression of functional receptors by the macrophages, and significant positive effect of free GMDP upon scavenger function of the peritoneal macrophages during endometriosis, it can be concluded that it is possible to try to increase the GMDP influence on macrophages by immobilization the GMDP on the silica nanoparticles. As significant difference in physical chemical and biological properties of the Fru-silica and Suc-silica was not revealed, the latter was chosen for further studies.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-18T06:27:49.008893+00:00
License: CC0 · commercial use OK